These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36881873)

  • 1. A Real-Time Image-Based Efferocytosis Assay for the Discovery of Functionally Inhibitory Anti-MerTK Antibodies.
    Bravo DD; Shi Y; Sheu A; Liang WC; Lin W; Wu Y; Yan M; Wang J
    J Immunol; 2023 Apr; 210(8):1166-1176. PubMed ID: 36881873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting MerTK decreases efferocytosis and increases anti-tumor immune infiltrate in prostate cancer.
    Myers Chen KV; de Groot AE; Mendez SA; Mallin MM; Amend SR; Pienta KJ
    Med Oncol; 2023 Aug; 40(10):284. PubMed ID: 37644281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of the Phagocytic Receptor MerTK on Tumor-Associated Macrophages Enhances P2X7R-Dependent STING Activation by Tumor-Derived cGAMP.
    Zhou Y; Fei M; Zhang G; Liang WC; Lin W; Wu Y; Piskol R; Ridgway J; McNamara E; Huang H; Zhang J; Oh J; Patel JM; Jakubiak D; Lau J; Blackwood B; Bravo DD; Shi Y; Wang J; Hu HM; Lee WP; Jesudason R; Sangaraju D; Modrusan Z; Anderson KR; Warming S; Roose-Girma M; Yan M
    Immunity; 2020 Feb; 52(2):357-373.e9. PubMed ID: 32049051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial cell-directed efferocytosis in the post-partum mammary gland is necessary for tissue homeostasis and future lactation.
    Sandahl M; Hunter DM; Strunk KE; Earp HS; Cook RS
    BMC Dev Biol; 2010 Dec; 10():122. PubMed ID: 21192804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efferocytosis is restricted by axon guidance molecule EphA4 via ERK/Stat6/MERTK signaling following brain injury.
    Soliman E; Leonard J; Basso EKG; Gershenson I; Ju J; Mills J; de Jager C; Kaloss AM; Elhassanny M; Pereira D; Chen M; Wang X; Theus MH
    J Neuroinflammation; 2023 Nov; 20(1):256. PubMed ID: 37941008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MERTK tyrosine kinase receptor together with TIM4 phosphatidylserine receptor mediates distinct signal transduction pathways for efferocytosis and cell proliferation.
    Nishi C; Yanagihashi Y; Segawa K; Nagata S
    J Biol Chem; 2019 May; 294(18):7221-7230. PubMed ID: 30846565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated expression of macrophage MERTK exhibits profibrotic effects and results in defective regulation of efferocytosis function in pulmonary fibrosis.
    She Y; Xu X; Yu Q; Yang X; He J; Tang XX
    Respir Res; 2023 Apr; 24(1):118. PubMed ID: 37120511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment-Induced Tumor Cell Apoptosis and Secondary Necrosis Drive Tumor Progression in the Residual Tumor Microenvironment through MerTK and IDO1.
    Werfel TA; Elion DL; Rahman B; Hicks DJ; Sanchez V; Gonzales-Ericsson PI; Nixon MJ; James JL; Balko JM; Scherle PA; Koblish HK; Cook RS
    Cancer Res; 2019 Jan; 79(1):171-182. PubMed ID: 30413412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A flexible high content imaging assay for profiling macrophage efferocytosis.
    Clark R; Usselmann L; Brown MR; Goeppert AU; Corrigan A
    J Immunol Methods; 2019 Oct; 473():112636. PubMed ID: 31369739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A+T rich interaction domain protein 3a (Arid3a) impairs Mertk-mediated efferocytosis in cholestasis.
    Chen R; Huang B; Lian M; Wei Y; Miao Q; Liang J; Ou Y; Liang X; Zhang H; Li Y; Xiao X; Wang Q; You Z; Chai J; Gershwin ME; Tang R; Ma X
    J Hepatol; 2023 Dec; 79(6):1478-1490. PubMed ID: 37659731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction.
    Wan E; Yeap XY; Dehn S; Terry R; Novak M; Zhang S; Iwata S; Han X; Homma S; Drosatos K; Lomasney J; Engman DM; Miller SD; Vaughan DE; Morrow JP; Kishore R; Thorp EB
    Circ Res; 2013 Sep; 113(8):1004-12. PubMed ID: 23836795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice.
    Thorp E; Cui D; Schrijvers DM; Kuriakose G; Tabas I
    Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1421-8. PubMed ID: 18451332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-dependent kinase activity of MERTK drives efferocytosis in human iPSC-derived macrophages.
    Wanke F; Gutbier S; Rümmelin A; Steinberg M; Hughes LD; Koenen M; Komuczki J; Regan-Komito D; Wagage S; Hesselmann J; Thoma R; Brugger D; Christopeit T; Wang H; Point F; Hallet R; Ghosh S; Rothlin CV; Patsch C; Geering B
    Cell Death Dis; 2021 May; 12(6):538. PubMed ID: 34035216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of MERTK receptor tyrosine kinase in epithelial cancer cells drives efferocytosis in a gain-of-function capacity.
    Nguyen KQ; Tsou WI; Calarese DA; Kimani SG; Singh S; Hsieh S; Liu Y; Lu B; Wu Y; Garforth SJ; Almo SC; Kotenko SV; Birge RB
    J Biol Chem; 2014 Sep; 289(37):25737-49. PubMed ID: 25074939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disturbed flow impairs MerTK-mediated efferocytosis in aortic endothelial cells during atherosclerosis.
    Wu J; Liu S; Banerjee O; Shi H; Xue B; Ding Z
    Theranostics; 2024; 14(6):2427-2441. PubMed ID: 38646649
    [No Abstract]   [Full Text] [Related]  

  • 16. RNA-based modulation of macrophage-mediated efferocytosis potentiates antitumor immunity in colorectal cancer.
    Zhou X; Li D; Xia S; Ma X; Li R; Mu Y; Liu Z; Zhang L; Zhou Q; Zhuo W; Ding K; Lin A; Liu W; Liu X; Zhou T
    J Control Release; 2024 Feb; 366():128-141. PubMed ID: 38104775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II deteriorates advanced atherosclerosis by promoting MerTK cleavage and impairing efferocytosis through the AT
    Zhang Y; Wang Y; Zhou D; Zhang LS; Deng FX; Shu S; Wang LJ; Wu Y; Guo N; Zhou J; Yuan ZY
    Am J Physiol Cell Physiol; 2019 Oct; 317(4):C776-C787. PubMed ID: 31390228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMS794833 inhibits macrophage efferocytosis by directly binding to MERTK and inhibiting its activity.
    Bae SH; Kim JH; Park TH; Lee K; Lee BI; Jang H
    Exp Mol Med; 2022 Sep; 54(9):1450-1460. PubMed ID: 36056187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-126 overexpression rescues diabetes-induced impairment in efferocytosis of apoptotic cardiomyocytes.
    Suresh Babu S; Thandavarayan RA; Joladarashi D; Jeyabal P; Krishnamurthy S; Bhimaraj A; Youker KA; Krishnamurthy P
    Sci Rep; 2016 Nov; 6():36207. PubMed ID: 27827458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the Immune Response to Tumor Cell Apoptosis and Efferocytosis.
    Werfel TA
    Methods Mol Biol; 2022; 2543():45-55. PubMed ID: 36087258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.